These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11059474)

  • 1. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.
    Neumann PJ; Sandberg EA; Araki SS; Kuntz KM; Feeny D; Weinstein MC
    Med Decis Making; 2000; 20(4):413-22. PubMed ID: 11059474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers.
    Neumann PJ; Kuntz KM; Leon J; Araki SS; Hermann RC; Hsu MA; Weinstein MC
    Med Care; 1999 Jan; 37(1):27-32. PubMed ID: 10413389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and construct validity of the health utilities index in patients with dementia.
    Kavirajan H; Hays RD; Vassar S; Vickrey BG
    Med Care; 2009 Jun; 47(6):651-61. PubMed ID: 19433998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
    Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
    Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons.
    Feeny D; Furlong W; Saigal S; Sun J
    Soc Sci Med; 2004 Feb; 58(4):799-809. PubMed ID: 14672594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
    Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
    Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
    Feldman H; Gauthier S; Hecker J; Vellas B; Hux M; Xu Y; Schwam EM; Shah S; Mastey V;
    Neurology; 2004 Aug; 63(4):644-50. PubMed ID: 15326236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference-based quality of life in patients with Alzheimer's disease.
    Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Glick HA
    Alzheimers Dement; 2008 May; 4(3):193-202. PubMed ID: 18631968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.
    Fuh JL; Wang SJ
    Int J Geriatr Psychiatry; 2008 Jan; 23(1):73-8. PubMed ID: 17520661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Qual Life Res; 2008 Aug; 17(6):933-42. PubMed ID: 18543076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.
    Raisch DW; Feeney P; Goff DC; Narayan KM; O'Connor PJ; Zhang P; Hire DG; Sullivan MD
    Cardiovasc Diabetol; 2012 Jul; 11():35. PubMed ID: 22515638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
    Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
    Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer.
    Nixon Speechley K; Maunsell E; Desmeules M; Schanzer D; Landgraf JM; Feeny DH; Barrera ME
    Int J Cancer Suppl; 1999; 12():95-105. PubMed ID: 10679879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy.
    Audhya I; Rogula B; Szabo SM; Feeny D; Bolatova T; Gooch K
    Health Qual Life Outcomes; 2023 Jul; 21(1):76. PubMed ID: 37468890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication.
    Bosch JL; Halpern EF; Gazelle GS
    Med Decis Making; 2002; 22(5):403-9. PubMed ID: 12365482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct validity for the Health Utilities Index in a sleep center.
    Welch KC; Scharf SM
    Sleep Breath; 2007 Dec; 11(4):295-303. PubMed ID: 17457630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between caregiver burden and caregiver health-related quality of life in Alzheimer disease.
    Bell CM; Araki SS; Neumann PJ
    Alzheimer Dis Assoc Disord; 2001; 15(3):129-36. PubMed ID: 11522930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three societally derived health-state classification values among older African Americans with depressive symptoms.
    Jutkowitz E; Pizzi L; Hess E; Suh DC; Gitlin LN
    Qual Life Res; 2013 Aug; 22(6):1491-8. PubMed ID: 22972437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients.
    Feeny D; Wu L; Eng K
    Qual Life Res; 2004 Dec; 13(10):1659-70. PubMed ID: 15651537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.